Recent advances in targeted therapy for exocrine pancreatic cancer

A tétel rövid nézete
dc.contributor.advisorMegyeri, Attila
dc.contributor.advisordeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.contributor.authorAl shaka, Asma
dc.contributor.departmentDE--Általános Orvostudományi Kar
dc.contributor.opponentSzentmiklósi, József
dc.contributor.opponentHalasi , Dóra Barbara
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Igazságügyi Orvostani Intézet
dc.date.accessioned2026-04-14T08:40:12Z
dc.date.available2026-04-14T08:40:12Z
dc.date.created2026-03-04
dc.description.abstractExocrine pancreatic cancer, mainly pancreatic ductal adenocarcinoma (PDAC), has a very poor prognosis and is one of the deadliest cancers worldwide because of its aggressive nature. It is often diagnosed at advanced stages, and standard chemotherapy usually has limited effectiveness. While improvements in surgical methods and the use of systemic chemotherapy have led to better outcomes for some patients, overall survival rates remain low. Recently, major advances in molecular and genetic studies have significantly improved our understanding of the biological processes behind PDAC progression. This progress has also helped in developing targeted therapies aimed at oncogenic drivers and parts of the tumor microenvironment. This paper will explore recent developments in targeted therapies for pancreatic cancer. It focuses on molecular targets such as KRAS and its signaling pathways, DNA damage repair mechanisms including BRCA1/2 mutations, and changes in cell cycle regulation and growth factor signaling. It will also examine results from relevant clinical trials. Furthermore, it will consider the importance of biomarker-driven patient selection and personalized treatment methods.
dc.description.courseáltalános orvos
dc.description.courselangangol
dc.description.coursespecOrvosbiológia-farmakológia
dc.description.degreeegységes, osztatlan
dc.format.extent36
dc.identifier.urihttps://hdl.handle.net/2437/406209
dc.language.isoen
dc.rights.infoHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectpancreatic cancer
dc.subjectTargeted therapy
dc.subjectExocrine pancreatic cancer
dc.subject.dspaceMedicine
dc.titleRecent advances in targeted therapy for exocrine pancreatic cancer
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
Recent advances in targeted therapy for exocrine pancreatic cancer .pdf
Méret:
1.19 MB
Formátum:
Adobe Portable Document Format
Leírás:
Megjelenítés
Engedélyek köteg
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
license.txt
Méret:
1.94 KB
Formátum:
Item-specific license agreed upon to submission
Leírás:
Letöltés
Gyűjtemények
Theses (Faculty of Medicine)